Skip to main content

Algorithm From EHR Can ID Common Variable Immunodeficiency Disease

Medically reviewed by Carmen Pope, BPharm. Last updated on May 2, 2024.

By Elana Gotkine HealthDay Reporter

THURSDAY, May 2, 2024 -- A machine learning algorithm can identify patients with common variable immunodeficiency disease (CVID) from their electronic health records, according to a study published in the May 1 issue of Science Translational Medicine.

Due to the low prevalence and extensive heterogeneity in CVID phenotypes, resulting in delayed diagnoses and treatments, Ruth Johnson, Ph.D., from the University of California in Los Angeles, and colleagues presented a machine learning algorithm (PheNet) to identify patients with CVID from their electronic health records.

The researchers note that PheNet learns phenotypic patterns from patients with CVID and uses this information to rank patients according to their likelihood of having CVID. More than half of the patients with CVID could have been diagnosed one or more years earlier than they were using PheNet. When applied to a large electronic health record database, 74 percent of the top 100 patients ranked by PheNet were highly probable to have CVID. PheNet was validated externally using more than 6 million records from disparate medical systems in California and Tennessee.

"Artificial intelligence approaches like PheNet can be used to expedite the referral of undiagnosed patients to immunologists," the authors write. "In the future, we will recruit patients identified by this algorithm to our immunology clinics. The impact of our work will benefit the rare disease community as there is an urgent need to identify patients early and efficiently."

Several authors disclosed ties to the biotechnology industry.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

High Level of Approval Observed for Polygenic Embryo Screening

FRIDAY, May 17, 2024 -- There is a high level of approval for use of polygenic embryo screening, according to a study published online May 14 in JAMA Network Open. Rémy A...

AI Chatbots Can Generate Quality, Empathetic, Readable Responses

FRIDAY, May 17, 2024 -- For patient questions about cancer, artificial intelligence (AI) chatbots can generate quality, empathetic, and readable responses, according to a study...

Slight Decline Seen in U.S. Drug Overdose Deaths

THURSDAY, May 16, 2024 -- New 2023 provisional data from the National Center for Health Statistics show the first decline in deaths from drug overdose in the United States since...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.